GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » COGS-to-Revenue

Lifeline Scientific (LSE:LSI) COGS-to-Revenue : 0.37 (As of Jun. 2016)


View and export this data going back to . Start your Free Trial

What is Lifeline Scientific COGS-to-Revenue?

Lifeline Scientific's Cost of Goods Sold for the six months ended in Jun. 2016 was £4.75 Mil. Its Revenue for the six months ended in Jun. 2016 was £12.80 Mil.

Lifeline Scientific's COGS to Revenue for the six months ended in Jun. 2016 was 0.37.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Lifeline Scientific's Gross Margin % for the six months ended in Jun. 2016 was 62.92%.


Lifeline Scientific COGS-to-Revenue Historical Data

The historical data trend for Lifeline Scientific's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific COGS-to-Revenue Chart

Lifeline Scientific Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.39 0.40 0.39 0.40

Lifeline Scientific Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.39 0.40 0.39 0.37

Lifeline Scientific COGS-to-Revenue Calculation

Lifeline Scientific's COGS to Revenue for the fiscal year that ended in Dec. 2015 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=10.465 / 26.31
=0.40

Lifeline Scientific's COGS to Revenue for the quarter that ended in Jun. 2016 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4.748 / 12.804
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifeline Scientific  (LSE:LSI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Lifeline Scientific's Gross Margin % for the six months ended in Jun. 2016 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 4.748 / 12.804
=62.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Lifeline Scientific COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifeline Scientific (LSE:LSI) Business Description

Traded in Other Exchanges
N/A
Address
Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.

Lifeline Scientific (LSE:LSI) Headlines

From GuruFocus

Life Storage, Inc. Announces Dividend on Common Stock

By Business Wire Business Wire 04-01-2022

Life Storage, Inc. Raises Quarterly Common Stock Dividend by 11%

By Business Wire Business Wire 01-03-2023

Life Storage, Inc. Reviewing Unsolicited Proposal from Public Storage

By Business Wire Business Wire 02-06-2023

Life Storage, Inc. Raises Quarterly Common Stock Dividend by 8%

By Business Wire Business Wire 07-05-2022